Download presentation
Presentation is loading. Please wait.
Published byHenry Anthony Modified over 5 years ago
1
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta- Analysis
Marieke H.J. van den Beuken-van Everdingen, MD, PhD, Laura M.J. Hochstenbach, MSc, Elbert A.J. Joosten, PhD, Vivianne C.G. Tjan- Heijnen, MD, PhD, Daisy J.A. Janssen, MD, PhD Journal of Pain and Symptom Management Volume 51, Issue 6, Pages e9 (June 2016) DOI: /j.jpainsymman Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
2
Fig. 1 Flow diagram of study selection.
Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
3
Fig. 2 Forest plot of pain prevalence after curative treatment (Group 1). Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
4
Fig. 3 Forest plot of pain prevalence in patients on anticancer treatment (Group 2). Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
5
Fig. 4 Forest plot of pain prevalence in patients with advanced, metastatic, or terminal disease (Group 3). Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
6
Fig. 5 Forest plot of pain prevalence in all stages (Group 4).
Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
7
Fig. 6 Forest plot of pain prevalence in patients after curative treatment or on anticancer treatment (Groups 1 and 2). Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
8
Fig. 7 Forest plot of pain prevalence in patients on anticancer treatment or with advanced, metastatic, or terminal disease (Groups 2 and 3). Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
9
Appendix II Distribution of Methodological Quality Scores
Journal of Pain and Symptom Management , e9DOI: ( /j.jpainsymman ) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.